2012
DOI: 10.1002/hep.25820
|View full text |Cite
|
Sign up to set email alerts
|

Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver

Abstract: Liver transplantation (LT) is a cure for many liver diseases. Blood chimerism of donor origin can develop after LT, which raises the possibility of the existence of hematopoietic stem/progenitor cells (HSPCs) in the liver. We characterized the blood chimerism in a large cohort of 249 LT patients and analyzed putative HSPCs in adult human livers. The overall incidence of chimerism was 6.43%, of which 11.11% was among short-term (1 day to 6 months) and 3.77% was among long-term (6 months to 8 years CD451 or CD4… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
42
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 42 publications
(43 citation statements)
references
References 28 publications
1
42
0
Order By: Relevance
“…We prefer the former hypothesis, because the population was maintained in liver grafts after extensive perfusion, but we did not exclude the probability of blood HSPCs in liver grafts. 1 With great interest we read the recent article in HEPATOLOGY by Rohr-Udilova et al, 1 who showed that reduced selenium (Se) levels and the subsequent reduced oxidative capacity lead to the accumulation of lipid peroxides producing reactive oxygen species (ROS) in patients with hepatocellular carcinoma (HCC). They set out to determine the effect of low Se levels on vascular endothelial growth factor (VEGF) and interleukin 8 (IL-8) expression, both of which are crucial in the development and growth of HCC.…”
Section: Replymentioning
confidence: 99%
See 1 more Smart Citation
“…We prefer the former hypothesis, because the population was maintained in liver grafts after extensive perfusion, but we did not exclude the probability of blood HSPCs in liver grafts. 1 With great interest we read the recent article in HEPATOLOGY by Rohr-Udilova et al, 1 who showed that reduced selenium (Se) levels and the subsequent reduced oxidative capacity lead to the accumulation of lipid peroxides producing reactive oxygen species (ROS) in patients with hepatocellular carcinoma (HCC). They set out to determine the effect of low Se levels on vascular endothelial growth factor (VEGF) and interleukin 8 (IL-8) expression, both of which are crucial in the development and growth of HCC.…”
Section: Replymentioning
confidence: 99%
“…1 Despite the valuable information added by the study, some issues caught our attention and, if clarified by the investigators, may greatly contribute to the knowledge on human immunodeficiency virus/hepatitis C virus (HIV/HCV) coinfection.…”
Section: The Prevalence Of Cirrhosis and Hepatocellular Carcinoma In mentioning
confidence: 99%
“…Phenotypically, hepatic NK cells have an activated phenotype with increased expression of the activation marker CD69 and the natural cytotoxicity receptor NKp44 ( There is accumulating evidence that the adult liver supports lymphopoiesis, and at least a proportion of hepatic NK cells may differentiate in situ from hematopoietic progenitors in the liver (12,13). NK cell precursors, isolated from adult liver, have been differentiated into functionally mature CD56 Bright and CD56 Dim NK cells, in vitro (14).…”
Section: Nk Cells In the Human Livermentioning
confidence: 99%
“…In this sense, the findings by Shi et al prove our hypothesis. 1 Regarding the origin of HSPCs, both consistent presences in liver or from blood HSPCs are possible. We prefer the former hypothesis, because the population was maintained in liver grafts after extensive perfusion, but we did not exclude the probability of blood HSPCs in liver grafts.…”
mentioning
confidence: 99%
“…We prefer the former hypothesis, because the population was maintained in liver grafts after extensive perfusion, but we did not exclude the probability of blood HSPCs in liver grafts. 1 With great interest we read the recent article in HEPATOLOGY by Rohr-Udilova et al, 1 who showed that reduced selenium (Se) levels and the subsequent reduced oxidative capacity lead to the accumulation of lipid peroxides producing reactive oxygen species (ROS) in patients with hepatocellular carcinoma (HCC). They set out to determine the effect of low Se levels on vascular endothelial growth factor (VEGF) and interleukin 8 (IL-8) expression, both of which are crucial in the development and growth of HCC.…”
mentioning
confidence: 99%